Citation

  • Authors: Juli, G., Gismondi, A., Monteleone, V., Caldarola, S., Iadevaia, V., Aspesi, A., Dianzani, I., Proud, C. G., Loreni, F.
  • Year: 2016
  • Journal: Sci Rep 6 35026
  • Applications: in vitro / siRNA / INTERFERin
  • Cell types:
    1. Name: K-562
      Description: Human chronic myelogenous leukaemia cells
      Known as: K562
    2. Name: 22Rv1
      Description: Human prostate carcinoma cells
      Known as:
    3. Name: HEK-293
      Description: Human embryonic kidney Fibroblast
      Known as: HEK293, 293

Method

Cells were transiently transfected with 100 nM siRNA using INTERFERin, according to the manufacturer's instructions. After 48 hours they were re-transfected and 48 hours later were harvested and analyzed.

Abstract

Ribosome biogenesis plays key roles in cell growth by providing increased capacity for protein synthesis. It requires coordinated production of ribosomal proteins (RP) and ribosomal RNA (rRNA), including the processing of the latter. Here, we show that, the depletion of RPS19 causes a reduction of rRNA synthesis in cell lines of both erythroid and non-erythroid origin. A similar effect is observed upon depletion of RPS6 or RPL11. The deficiency of RPS19 does not alter the stability of rRNA, but instead leads to an inhibition of RNA Polymerase I (Pol I) activity. In fact, results of nuclear run-on assays and ChIP experiments show that association of Pol I with the rRNA gene is reduced in RPS19-depleted cells. The phosphorylation of three known regulators of Pol I, CDK2, AKT and AMPK, is altered during ribosomal stress and could be involved in the observed downregulation. Finally, RNA from patients with Diamond Blackfan Anemia (DBA), shows, on average, a lower level of 47S precursor. This indicates that inhibition of rRNA synthesis could be one of the molecular alterations at the basis of DBA.

Pubmed